Sponsor Pipeline

Haihe Biopharma Co., Ltd. Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
5
Active Trials
4
Recruiting
2
Disease Areas
Active Trials by Phase
Phase 2
1
Phase 1/2
4
Active Trials
NCT IDTitleConditionStatus
Phase 2
NCT05043922 A Study to Evaluate the Efficacy and Safety of CYH33 in Patients With… Ovarian Cancer Active, Not Recruiting
Phase 1/2
NCT04270591 Assessment of Anti-tumor and Safety in Glumetinib in Patients With c-MET-positive… C-Met Exon 14 Mutation Recruiting
NCT04390737 Evaluate the Safety and Clinical Activity of HH2853 FL Lymphoma Recruiting
NCT06909877 Study to Evaluate Efficacy and Safety of HH2853 in Relapsed/Refractory Peripheral T-cell… Relapsed/Refractory Peripheral T-Cell Lymphoma (R/R PTCL) Recruiting
NCT06975618 Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Preliminary Efficacy of… PIK3CA-Related Overgrowth Spectrum (PROS) Recruiting
Disease Areas
Get alerts when Haihe Biopharma Co., Ltd.'s trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free